Attached files

file filename
EX-10.17 - EXHIBIT 10.17 - Sagimet Biosciences Inc.tm218447d4_ex10-17.htm
EX-10.16 - EXHBIT 10.16 - Sagimet Biosciences Inc.tm218447d4_ex10-16.htm
EX-10.15 - EXHIBIT 10.15 - Sagimet Biosciences Inc.tm218447d4_ex10-15.htm
EX-10.14 - EXHIBIT 10.14 - Sagimet Biosciences Inc.tm218447d4_ex10-14.htm
EX-10.10 - EXHIBIT 10.10 - Sagimet Biosciences Inc.tm218447d4_ex10-10.htm
EX-10.4 - EXHIBIT 10.4 - Sagimet Biosciences Inc.tm218447d4_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Sagimet Biosciences Inc.tm218447d4_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Sagimet Biosciences Inc.tm218447d4_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Sagimet Biosciences Inc.tm218447d4_ex10-1.htm
EX-4.2 - EXHIBIT 4.2 - Sagimet Biosciences Inc.tm218447d4_ex4-2.htm
EX-3.3 - EXHIBIT 3.3 - Sagimet Biosciences Inc.tm218447d4_ex3-3.htm
EX-3.1 - EXHIBIT 3.1 - Sagimet Biosciences Inc.tm218447d4_ex3-1.htm
S-1 - S-1 - Sagimet Biosciences Inc.tm218447-3_drs.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the use in this Registration Statement on Form S-1 of our report dated March 10, 2021, relating to the financial statements of Sagimet Biosciences Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

 

/s/ Deloitte & Touche LLP

 

San Jose, California

 

April 16, 2021